PsychEd: Educational Psychiatry Podcast

PsychEd Episode 34: Ketamine for Treatment-Resistant Depression with Dr. Sandhya Prashad


Listen Later

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.

This episode covers ketamine for treatment-resistant depression (TRD) with Dr. Sandhya Prashad, a psychiatrist and the founder and medical director of Houston Ketamine Therapeutics. She has extensive expertise using ketamine and is one of the most experienced ketamine psychiatrists in the United States, with her clinical practice focusing on TRD and incorporating transcranial magnetic stimulation (TMS), sometimes in conjunction with ketamine. Dr. Prashad is also a founding member and current president of the American Society of Ketamine Physicians (ASKP), a non-profit organization created to advocate for the safe use of ketamine for mental illness and pain disorders and to expand access to ketamine therapy.

 

We’re also experimenting with something new for this episode — providing a transcript of the entire interview! The transcript can be found at psychedpodcast.org/transcripts/ketamine. We’d love to hear your feedback as listeners on this as a feature, including whether it’s something you’d be interested in seeing for other episodes moving forward!

 

The learning objectives for this episode are as follows:

 

By the end of this episode, you should be able to…

  1. Describe ketamine and how it came to be used in the field of psychiatry.
  2. Develop an appreciation for benefits and potential harms associated with ketamine and how this compares to other treatments for depression.
  3. Understand how ketamine fits into the treatment of depression and suicidality, patient characteristics to consider before initiation, potential mechanisms of action, different models of administration, and incorporation of psychotherapy.

 

Guest expert: Dr. Sandhya Prashad

 

Hosts: Jimmy Qian (MS2), Dr. Nikhita Singhal (PGY2), Dr. Chase Thompson (PGY3)

 

Audio editing by: Dr. Chase Thompson

 

Show notes by: Gray Meckling (MS4)

 

Interview transcript by: Gray Meckling

 

00:00 – Introduction

03:00 – Learning objectives

03:30 – History of ketamine

06:20 – Recreational use of ketamine, phenomenology of the ketamine experience

09:45 – Where does ketamine fall in the algorithm for treatment of depression?

11:50 – Ketamine’s use in acute suicidality

13:40 – Ketamine contraindications

14:40 – Ketamine efficacy

19:00 – Combining ketamine with rTMS

21:15 – Limitations to ketamine

24:35 – Ketamine mechanism of action

26:05 – Ketamine formulations, and integrating ketamine into psychotherapy

33:10 – Combining ketamine with traditional antidepressant treatment

37:30 – Practicalities of administering ketamine

39:40 – Ketamine as treatment for OCD and PTSD

41:40 – Closing remarks

 

Resources:

  • American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP)
  • Sandhya Prashad, MD (Website)
  • NEJM interview with Dr. Roy Perlis: Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class

 

References:

  • Berman, R., Cappiello, A., Anand, A., Oren, D., Heninger, G., Charney, D.. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351–354.
  • Daly, E. J., Trivedi, M. H., Janik, A., Li, H., Zhang, Y., Li, X., ... & Thase, M. E. (2019). Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA psychiatry76(9), 893-903.
  • J.W. Murrough, D.V. Iosifescu, L.C. Chang, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two site randomized controlled trial. Am. J. Psychiatry, 2013 (170) (2013), pp. 1134-1142
  • Kim, J., Farchione, T., Potter, A., Chen, Q., & Temple, R. (2019). Esketamine for treatment-resistant depression-first FDA-approved antidepressant in a new class. N Engl J Med381(1), 1-4.
  • McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., ... & Stahl, S. (2021). Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. American Journal of Psychiatry, appi-ajp.
  • Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJA, Curran HV. Journey through the K-hole: Phenomenological aspects of ketamine use. Drug and Alcohol Dependence [Internet]. 2008 Jun 1;95(3):219–29.
  • Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA psychiatry. 2017 Apr 1;74(4):399-405.
  • Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J, Birnbaum J, Lyons DM, Rodriguez CI, Schatzberg AF. Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. American Journal of Psychiatry. 2018 Dec 1;175(12):1205-15.
  • Williams NR, Heifets BD, Bentzley BS, Blasey C, Sudheimer KD, Hawkins J, Lyons DM, Schatzberg AF. Attenuation of antidepressant and anti suicidal effects of ketamine by opioid receptor antagonism. Molecular psychiatry. 2019 Dec;24(12):1779-86.
  • Zarate, C., Singh, J., Carlson, P., Brutsche, N., Ameli, R., Luckenbaugh, D.. (2006a) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856–864.

 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association (CPA).


For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at [email protected]. For more information, visit our website at psychedpodcast.org.

...more
View all episodesView all episodes
Download on the App Store

PsychEd: Educational Psychiatry PodcastBy PsychEd

  • 4.6
  • 4.6
  • 4.6
  • 4.6
  • 4.6

4.6

147 ratings


More shows like PsychEd: Educational Psychiatry Podcast

View all
Speaking of Psychology by American Psychological Association

Speaking of Psychology

68 Listeners

Emergency Medicine Cases by Dr. Anton Helman

Emergency Medicine Cases

548 Listeners

American Journal of Psychiatry Audio by American Journal of Psychiatry

American Journal of Psychiatry Audio

75 Listeners

NEI Podcast by Neuroscience Education Institute

NEI Podcast

152 Listeners

Being Well with Forrest Hanson and Dr. Rick Hanson by Rick Hanson, Ph.D., Forrest Hanson

Being Well with Forrest Hanson and Dr. Rick Hanson

2,505 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,340 Listeners

The mindbodygreen Podcast by mindbodygreen

The mindbodygreen Podcast

2,049 Listeners

Core IM | Internal Medicine Podcast by Core IM Team

Core IM | Internal Medicine Podcast

1,150 Listeners

Psychiatry & Psychotherapy Podcast by David Puder, M.D.

Psychiatry & Psychotherapy Podcast

1,342 Listeners

Psychopharmacology and Psychiatry Updates by Psychopharmacology Institute

Psychopharmacology and Psychiatry Updates

287 Listeners

The Zero to Finals Medical Revision Podcast by Thomas Watchman

The Zero to Finals Medical Revision Podcast

144 Listeners

The Carlat Psychiatry Podcast by Pocket Psychiatry: A Carlat Podcast

The Carlat Psychiatry Podcast

574 Listeners

Back from the Abyss: Psychiatry in Stories by Craig Heacock MD

Back from the Abyss: Psychiatry in Stories

472 Listeners

Psychiatry Boot Camp by Mark Mullen, MD

Psychiatry Boot Camp

187 Listeners

PsychRounds: The Psychiatry Podcast by Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller

PsychRounds: The Psychiatry Podcast

138 Listeners